European doctors have insufficient knowledge of biosimilars

28.03.2014

GaBi Online

The Alliance for Safe Biologic Medicines (ASBM), which represents patients and physicians, as well as originator biological and biosimilar medicines companies in the US, published results of a survey on 18 March 2014, which showed that physicians in Europe have insufficient knowledge of biosimilars [1].

The survey, which was carried out in the third quarter of 2013, questioned 470 European physicians across five countries (France, Germany, Italy, Spain and UK) about their prescribing habits and knowledge of biosimilars. Specialists in nephrology, rheumatology, dermatology, neurology, endocrinology and oncology were included in the research, which was carried out via a 15 minute web-based survey.

The full article is available here.